These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis. Das A, Sil A, Sarkar TK, Sen A, Chakravorty S, Sengupta M, Das A, Chandra S, Pal S, Bandyopadhyay D, Das NK. Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926 [Abstract] [Full Text] [Related]
9. Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: A randomised, assessor-blinded comparative study. Lal NR, Basu D, Saha A, Ghosh R, Verma R, Bandyopadhyay D. Indian J Dermatol Venereol Leprol; 2023; 89(5):665-671. PubMed ID: 36688883 [Abstract] [Full Text] [Related]
16. Efficacy, Safety, and Cost Evaluation of the Topical Luliconazole Therapy versus Topical Clotrimazole Therapy in Patients with Localized Dermatophytosis in a Tertiary Care Hospital: An Observational Study. Kaur M, Gupta A, Mahajan R, Gill M. Int J Appl Basic Med Res; 2020 Jul; 10(4):260-264. PubMed ID: 33376700 [Abstract] [Full Text] [Related]
18. Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis. Borelli C, Klövekorn G, Ernst TM, Bödeker RH, Korting HC, Neumeister C. Am J Clin Dermatol; 2007 Jul; 8(6):371-8. PubMed ID: 18039020 [Abstract] [Full Text] [Related]